Market Research Logo

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.

This report provides:
An overview of the global markets for gastrointestinal therapeutics and diagnostics. 
Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
Analyses of therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact.
Descriptions of the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future.
Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities.
Profiles of major players in the industry.


SCOPE OF REPORT

This report is designed to provide an in-depth look at the therapeutic and diagnostic options of various gastrointestinal disorders. The geographic scope of the report is global, with particular emphasis on the key markets such as the U.S. and the European Union Five (EU5). The estimated market data is also global in nature, with geographic segments such as the U.S., EU and Rest of the World (ROW). The report provides a brief overview of the gastrointestinal system, which provides an introduction to the disorders of the gastrointestinal system; cites risk factors, where applicable; presents current pharmaceutical treatments, market size and key market participants (both prescription and OTC); and presents potential treatments in R&D, potential market size and future market entrants.

As already mentioned, the market for gastrointestinal pharmaceuticals is divided into two general segments: prescription gastrointestinal pharmaceuticals and OTC gastrointestinal pharmaceuticals. Similarly, the market for gastrointestinal diagnostics, testing and vaccines is divided into three general segments:
Diagnostics and testing market.
Medical devices (endoscopy) 
Vaccines.

The market is further broken down into the drugs to treat specific disorders within the gastrointestinal system, including the following:
Gastrointestinal tract disorders.
Gastrointestinal tract walls disorders.
Gastrointestinal motility disorders.
Gastrointestinal cancers.
Each sub-segment is covered in detail, describing the disorders and diseases, identifying currently available and potential products, and competitors.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY AND INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
GASTROINTESTINAL THERAPEUTICS AND DIAGNOSTICS
ANTIDIARRHEALS
ANTIEMETICS
GASTRIC CANCER
GASTROESOPHAGEAL REFLUX DISEASE TREATMENTS
LAXATIVES
INFLAMMATORY BOWEL DISEASES
OTHER GI DRUGS
SUMMARY TABLE GLOBAL MARKET FOR GASTROINTESTINAL DISORDER THERAPEUTICS AND DIAGNOSTICS, BY CATEGORY, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR GASTROINTESTINAL DISORDER THERAPEUTICS AND DIAGNOSTICS, BY CATEGORY, 2015-2021 ($ MILLIONS)
CHAPTER 3 OVERVIEW
TABLE 1 U.S. INCIDENCE OF INDIVIDUAL PATHOGENS
TABLE 2 ESTIMATED INCIDENCE/PREVALENCE/MORTALITY OF SELECTED GI
CONDITIONS IN THE U.S.
GASTRIC CANCER
TABLE 3 GASTRIC CANCER PREVALENCE, 2012-2021 (THOUSANDS)
INFLAMMATORY BOWEL DISEASE (IBD)
TABLE 4 PREVALENCE ESTIMATES OF IBD, BY COUNTRY (%)
TABLE 5 U.S. PREVALENCE OF INFLAMMATORY BOWEL DISEASE (NUMBER OF CASES PER 100,000 POPULATION)
TABLE 6 U.S. INCIDENCE OF INFLAMMATORY BOWEL DISEASE (NUMBER OF NEWLY DIAGNOSED CASES PER 100,000 PERSON-YEARS)
TABLE 7 GLOBAL PREVALENCE OF INFLAMMATORY BOWEL DISEASE
CONSTIPATION
OPIOID-INDUCED CONSTIPATION
TABLE 8 COMMONLY USED LAXATIVE AGENTS
GASTROESOPHAGEAL REFLUX DISEASE
TABLE 9 PREVALENCE OF GERD SYMPTOMS (%)
CHAPTER 4 ETIOLOGY
ANATOMY AND PHYSIOLOGY OF THE GASTROINTESTINAL SYSTEM
STRUCTURE OF GI SYSTEM
INTERACTIONS WITH OTHER SYSTEMS
Nervous System
THE ENTERIC NERVOUS SYSTEM: AN OVERVIEW
FACTORS AFFECTING THE FUNCTIONING OF THE GI SYSTEM
PHYSIOLOGY OF THE GI SYSTEM AND THE ROLE OF EACH PART IN THE GI
PROCESS
INGESTION AND DEGLUTITION
Mouth
Pharynx
Esophagus
DIGESTION
Mouth
Stomach
Small Intestines
ABSORPTION
ELIMINATION
Large Intestine
ORGANS OF THE GASTROINTESTINAL SYSTEM
Liver
Biliary Tract
Pancreas
DISORDERS AND ANOMALIES OF THE GI TRACT
Dysphagia
Esophageal Pain
Abdominal Pain
Constipation
Diarrhea
DISORDERS OF THE GASTROINTESTINAL TRACT WALLS
Gastritis
Gastroenteritis
Peptic Ulcers
Gastric Ulcers
Duodenal Ulcers
INFLAMMATORY BOWEL DISEASE
Ulcerative Colitis
Crohn's Disease
Enterocolitis
DIVERTICULAR DISEASE
ANOMALIES GASTROINTESTINAL TRACT MOTILITY
Irritable Bowel Syndrome
Intestinal Obstructions
DISORDERS RELATED TO GASTROINTESTINAL MALABSORPTION
Celiac Sprue
Tropical Sprue
CANCERS OF THE GASTROINTESTINAL SYSTEM
Esophageal Cancer
Gastric Cancer
Liver Cancer
Pancreatic Cancer
Small Intestinal Cancer
Colonic Polyps and Colon Cancer
LATEST TREATMENT AND PROGNOSIS METHODS FOR CANCER OF THE GI
SYSTEM
PILL-SIZED VIDEO CAMERA: PILLCAM ESO
SmartPill
Monoclonal Antibodies
INSURANCE COVERAGE FOR TREATMENT
TABLE 10 U.S. STATES THAT PROVIDE COMPLETE RANGE OF COLORECTAL DIAGNOSTIC SCREENING
LATEST RESEARCH TRENDS AND STUDIES IN GASTROINTESTINAL FIELD
Radio Frequency Identification Technology
Generic Influence and Penetration
BRANDED VS. OTC PROTON PUMP INHIBITORS
MAIL ORDER TRENDS
MOBILE APPLICATION
CHAPTER 5 PRESCRIPTION THERAPY MARKET
TABLE 11 GLOBAL MARKET FOR PRESCRIPTION GI THERAPIES, BY CATEGORY, THROUGH 2021 ($ MILLIONS)
ANTIDIARRHEALS
SYSTEMICALLY ACTING ANTIDIARRHEALS
OPIUM DERIVATIVES
TABLE 12 KEY ANTI-DIARRHEAL BRANDS
MARKET SIZE AND GROWTH
TABLE 13 GLOBAL MARKET FOR PRESCRIPTION ANTIDIARRHEAL THERAPIES, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 1 GLOBAL MARKET FOR PRESCRIPTION ANTIDIARRHEAL THERAPIES, BY REGION, 2015-2021 ($ MILLIONS)
ANTIEMETICS
TABLE 14 ANTIEMETICS: SITE OF ACTION AND EXAMPLES
LOCALLY ACTING ANTIEMETICS
CENTRALLY ACTING ANTIEMETICS
Antidopaminergics
Phenothiazines
Metochlopramide
ANTICHOLINERGICS
SEROTONIN RECEPTOR ANTAGONISTS
Neurokinin-1 Receptor Antagonists
MISCELLANEOUS ANTIEMETICS
TABLE 15 MARKETED ANTIEMETIC PRODUCTS
MARKET SIZE AND GROWTH
TABLE 16 GLOBAL MARKET FOR PRESCRIPTION ANTIEMETIC THERAPIES, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 2 GLOBAL MARKET FOR PRESCRIPTION ANTIEMETIC THERAPIES, BY REGION, 2015-2021 ($ MILLIONS)
GASTROINTESTINAL CANCER TREATMENTS
BIOLOGICS
TABLE 17 MARKETED GASTROINTESTINAL CANCER PRODUCTS
MARKET SIZE AND GROWTH
TABLE 18 GLOBAL PRESCRIPTION GASTROINTESTINAL CANCER THERAPIES, BY REGION, THROUGH 2021 ($ MILLIONS
FIGURE 3 GLOBAL PRESCRIPTION GASTROINTESTINAL CANCER THERAPIES, BY REGION, 2015-2021 ($ MILLIONS)
GASTROESOPHAGEAL REFLUX DISEASE TREATMENTS
H2 INHIBITORS
TABLE 19 MARKETED H2 INHIBITOR PRODUCTS
MARKET SIZE AND GROWTH
TABLE 20 GLOBAL PRESCRIPTION H2 INHIBITOR MARKET, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 4 GLOBAL PRESCRIPTION H2 INHIBITOR MARKET, BY REGION, 2015-2021 ($ MILLIONS)
PROTON PUMP INHIBITORS
TABLE 21 PROTON PUMP INHIBITORS: THERAPY AND PH
TABLE 22 MARKETED PROTON PUMP INHIBITOR PRODUCTS
MARKET SIZE AND GROWTH
TABLE 23 GLOBAL PRESCRIPTION PROTON PUMP INHIBITOR MARKET, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 5 GLOBAL PRESCRIPTION PROTON PUMP INHIBITOR MARKET, BY REGION, 2015-2021 ($ MILLIONS)
LAXATIVES
TABLE 24 PHARMACOLOGIC MANAGEMENT OF CHRONIC CONSTIPATION IN THE U.S.
TABLE 25 MARKETED LAXATIVE PRODUCTS
TABLE 26 PHARMACOLOGIC MANAGEMENT OF CHRONIC CONSTIPATION (IN AND OUTSIDE THE U.S.)
MARKET SIZE AND GROWTH
TABLE 27 GLOBAL PRESCRIPTION LAXATIVE MARKET, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 6 GLOBAL PRESCRIPTION LAXATIVE MARKET, BY REGION, 2015-2021 ($ MILLIONS)
BOWEL ANTI-INFLAMMATORY
TABLE 28 MARKETED ANTI-INFLAMMATORY BOWEL PRODUCTS
MARKET SIZE AND GROWTH
TABLE 29 GLOBAL MARKET FOR PRESCRIPTION BOWEL ANT-INFLAMMATORIES, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 7 GLOBAL MARKET FOR PRESCRIPTION BOWEL ANTI-INFLAMMATORIES, BY REGION, 2015-2021 ($ MILLIONS)
OTHER GI DRUGS
MARKET SIZE AND GROWTH
TABLE 30 GLOBAL MARKET FOR OTHER PRESCRIPTION GASTROINTESTINAL THERAPIES, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 8 GLOBAL MARKET FOR OTHER PRESCRIPTION
GASTROINTESTINAL THERAPIES, BY REGION, 2015-2021($ MILLIONS)
CHAPTER 6 OTC THERAPY MARKET
ANTACIDS
SYSTEMIC ANTACIDS
Sodium Bicarbonate
NONSYSTEMIC ANTACIDS
Calcium Carbonate
Aluminum Products
Magnesium Products
Combination Products
TABLE 31 KEY BRANDS OF ANTACIDS IN U.S. AND OTHER MARKETS
MARKET SIZE AND GROWTH
TABLE 32 GLOBAL OTC ANTACID MARKET, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 9 GLOBAL OTC ANTACID MARKET, BY REGION, 2015-2021 ($ MILLIONS)
LOCALLY ACTING ANTIDIARRHEALS
INTESTINAL FLORA MODIFIERS
TABLE 33 MARKETED OTC ANTIDIARRHEAL PRODUCTS
MARKET SIZE AND GROWTH
TABLE 34 GLOBAL OTC ANTIDIARRHEAL MARKET, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 10 GLOBAL OTC ANTIDIARRHEAL MARKET, BY REGION, 2015-2021 ($ MILLIONS)
H2 INHIBITORS
TABLE 35 MARKETED OTC H2 INHIBITOR PRODUCTS
MARKET SIZE AND GROWTH
TABLE 36 GLOBAL MARKET FOR OTC H2 INHIBITORS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 11 GLOBAL MARKET FOR OTC H2 INHIBITORS, BY REGION, 2015-2021 ($ MILLIONS)
PROTON PUMP INHIBITORS
OMEPRAZOLE (PRILOSEC, PROCTER & GAMBLE)
TABLE 37 MARKETED OTC PROTON PUMP INHIBITOR PRODUCTS
MARKET SIZE AND GROWTH
TABLE 38 GLOBAL MARKET FOR OTC PROTON PUMP INHIBITORS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 12 GLOBAL MARKET FOR OTC PROTON PUMP INHIBITORS, BY REGION, 2015-2021 ($ MILLIONS)
LAXATIVES
TABLE 39 MARKETED OTC LAXATIVE PRODUCTS
MARKET SIZE AND GROWTH
TABLE 40 GLOBAL OTC LAXATIVE MARKET, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 13 GLOBAL OTC LAXATIVE MARKET, BY REGION, 2015-2021 ($ MILLIONS)
TOTAL OTC GASTROINTESTINAL DRUG MARKET SIZE AND GROWTH
TABLE 41 GLOBAL MARKET FOR OTC GASTROINTESTINAL DRUGS, BY PRODUCT CATEGORY, THROUGH 2021 ($ MILLIONS)
FIGURE 14 GLOBAL MARKET FOR OTC GASTROINTESTINAL DRUGS, BY PRODUCT CATEGORY, 2015-2021 ($ MILLIONS)
CHAPTER 7 DIAGNOSTICS AND DEVICES MARKET
ENTERIC DISEASE TESTING METHODS
TABLE 42 ENTERIC DISEASE TESTING METHODS
TABLE 43 ENTERIC DISEASE DIAGNOSTICS, BY DISEASE TYPE GLOBAL MARKET FOR ENTERIC DIAGNOSTIC TESTS
TABLE 44 GLOBAL MARKET FOR DIAGNOSTICS FOR GI DISEASES, BY TYPE, THROUGH 2021 ($ MILLIONS)
FIGURE 15 GLOBAL MARKET FOR DIAGNOSTICS FOR GI DISEASES, BY TYPE, 2015-2021 ($ MILLIONS)
CAMPYLOBACTER
FILMARRAY GASTROINTESTINAL (GI) PANEL
TABLE 45 COMMERCIALLY AVAILABLE MOLECULAR TESTS FOR CAMPYLOBACTER AND SALMONELLA
MARKET SIZE AND GROWTH
TABLE 46 GLOBAL MARKET FOR CAMPYLOBACTER DIAGNOSTIC TESTS, BY REGION,THROUGH 2021 ($ MILLIONS)
FIGURE 16 GLOBAL MARKET FOR CAMPYLOBACTER DIAGNOSTIC TESTS, BY REGION, 2015-2021 ($ MILLIONS)
NOROVIRUS
LABORATORY TESTS
IMMUNOLOGICAL TESTS
ELISA
RT-QPCR ASSAYS
CONVENTIONAL RT-PCR ASSAYS FOR GENOTYPING
ENZYME IMMUNOASSAYS
MULTIPLEX TESTING
TABLE 47 COMMERCIALLY AVAILABLE MOLECULAR TESTS FOR NOROVIRUSES
Multiplex PCRs
Luminex Multiplex PCR
FOODPROOF NOROVIRUS DETECTION KIT (GI, GII, GIV)
Next-Generation Sequencing (NGS)
MARKET SIZE AND GROWTH
TABLE 48 GLOBAL MARKET FOR NOROVIRUS DIAGNOSTIC TESTS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 17 GLOBAL MARKET FOR NOROVIRUS DIAGNOSTIC TESTS, BY REGION, 2015-2021 ($ MILLIONS)
ROTAVIRUS
LUMINEX GASTROINTESTINAL PATHOGEN PANEL
TABLE 49 COMMERCIALLY AVAILABLE MOLECULAR TESTS FOR ROTAVIRUS
MARKET SIZE AND GROWTH
TABLE 50 GLOBAL MARKET FOR ROTAVIRUS DIAGNOSTIC TESTS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 18 GLOBAL MARKET FOR ROTAVIRUS DIAGNOSTIC TESTS, BY REGION, 2015-2021 ($ MILLIONS)
GIARDIA PARASITE
REVERSE TRANSCRIPTASE PCR
HIGH-RESOLUTION MELT CURVE ANALYSIS
PCR-RESTRICTION FRAGMENT LENGTH POLYMORPHISM
SINGLE-STRAND CONFORMATION POLYMORPHISM
PCR-REVERSE LINE BLOT ASSAY
TABLE 51 COMMERCIALLY AVAILABLE MOLECULAR TESTS FOR GIARDIA
PARASITE
MARKET SIZE AND GROWTH
TABLE 52 GLOBAL MARKET FOR GIARDIA PARASITE DIAGNOSTIC TESTS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 19 GLOBAL MARKET FOR GIARDIA PARASITE DIAGNOSTIC TESTS, BY REGION, 2015-2021 ($ MILLIONS)
E. COLI
TABLE 53 COMMERCIALLY AVAILABLE MOLECULAR TESTS FOR E. COLI MARKET SIZE AND GROWTH
TABLE 54 GLOBAL MARKET FOR E. COLI DIAGNOSTIC TESTS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 20 GLOBAL MARKET FOR E. COLI DIAGNOSTIC TESTS, BY REGION, 2015-2021 ($ MILLIONS)
CRYPTOSPORIDIUM
ACID-STAINING TEST
TABLE 55 COMMERCIALLY AVAILABLE MOLECULAR TESTS FOR CRYPTOSPORIDIUM
MARKET SIZE AND GROWTH
TABLE 56 GLOBAL MARKET FOR CRYPTOSPORIDIUM DIAGNOSTIC TESTS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 21 GLOBAL MARKET FOR CRYPTOSPORIDIUM DIAGNOSTIC TESTS, BY REGION, 2015-2021 ($ MILLIONS)
SHIGELLA
TABLE 57 COMMERCIALLY AVAILABLE MOLECULAR TESTS FOR SHIGELLA MARKET SIZE AND GROWTH
TABLE 58 GLOBAL MARKET FOR SHIGELLA DIAGNOSTIC TESTS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 22 GLOBAL MARKET FOR SHIGELLA DIAGNOSTIC TESTS, BY REGION, 2015-2021 ($ MILLIONS)
TYPHOID
TABLE 59 COMMERCIALLY AVAILABLE MOLECULAR TESTS FOR SALMONELLA
MARKET SIZE AND GROWTH
TABLE 60 GLOBAL MARKET FOR TYPHOID DIAGNOSTIC TESTS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 23 GLOBAL MARKET FOR TYPHOID DIAGNOSTIC TESTS, BY REGION, 2015-2021 ($ MILLIONS)
AMEBIASIS
TABLE 61 COMMERCIALLY AVAILABLE MOLECULAR TESTS FOR AMEBIASIS MARKET SIZE AND GROWTH
TABLE 62 GLOBAL MARKET FOR AMEBIASIS DIAGNOSTIC TESTS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 24 GLOBAL MARKET FOR AMEBIASIS DIAGNOSTIC TESTS, BY REGION, 2015-2021 ($ MILLIONS)
CHOLERA
TABLE 63 COMMERCIALLY AVAILABLE MOLECULAR TESTS FOR CHOLERA MARKET SIZE AND GROWTH
TABLE 64 GLOBAL MARKET FOR CHOLERA DIAGNOSTIC TESTS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 25 GLOBAL MARKET FOR CHOLERA DIAGNOSTIC TESTS, BY REGION, 2015-2021 ($ MILLIONS)
OTHER (H. PYLORI, YERSINIA) DIAGNOSTIC TESTS
TABLE 65 COMMERCIALLY AVAILABLE MOLECULAR TESTS FOR H. PYLORI
MARKET SIZE AND GROWTH
TABLE 66 GLOBAL MARKET FOR OTHER (SALMONELLA, H. PYLORI)
DIAGNOSTIC TESTS, BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 26 GLOBAL MARKET FOR OTHER (SALMONELLA, H. PYLORI)
DIAGNOSTIC TESTS, BY REGION, 2015-2021 ($ MILLIONS)
MEDICAL DEVICES (ENDOSCOPY)
TABLE 67 EMERGING NOVEL DIAGNOSTIC AND THERAPEUTIC
ENDOSCOPIC TECHNIQUES
NEW DIAGNOSTIC ENDOSCOPIC TECHNIQUES
Endoscopic Ultrasound
Radio-controlled, Motor-driven Capsule (Robotic Endoscopy)
NEW TECHNOLOGY IN THERAPY OF GI CANCERS
Natural Orifice Transluminal Endoscopic Surgery (NOTES) Technique
Per-oral Endoscopic Myotomy
Endoscopic Mucosal Resection
Radiofrequency Ablation
MARKET SIZE AND GROWTH
TABLE 68 GLOBAL MARKET FOR MEDICAL DEVICES (ENDOSCOPY), BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 27 GLOBAL MARKET FOR MEDICAL DEVICES (ENDOSCOPY), BY REGION, 2015-2021 ($ MILLIONS)
MARKET SIZE AND GROWTH
TABLE 69 GLOBAL MARKET FOR GASTRO-DIAGNOSTICS, THROUGH 2021 ($ MILLIONS)
FIGURE 28 GLOBAL MARKET FOR GASTRO-DIAGNOSTICS, 2015-2021 ($ MILLIONS)
CHAPTER 8 GASTROINTESTINAL PRODUCT PIPELINE
THERAPIES FOR TREATING GASTRIC CANCER
RAMUCIRUMAB (LY3009806)
RG1273 (RO4368451)
TAS-118
KEYTRUDA (PEMBROLIZUMAB)
AVELUMAB (PF 06834635)
PERTUZUMAB
TABLE 70 DEVELOPMENTAL PIPELINE OF GI THERAPIES
GERD AND PEPTIC ULCERS
VONOPRAZAN (TAK-438)
THERAPIES FOR TREATING IBS
LINACLOTIDE
IBODUTANT
PLECANATIDE
TENAPANOR
ALOSETRON
THERAPIES FOR TREATING ULCERATIVE COLITIS AND CROHN’S DISEASE
ETROLIZUMAB
OZANIMOD
XELJANZ (TOFACITINIB)
TAK-114
LY3074828
GED 0301 (MONGERSEN)
CHAPTER 9 PATENTS
TABLE 71 PATENTS ISSUED
TABLE 72 PATENTS APPLIED
CHAPTER 10 COMPANY PROFILES
ALLERGAN PLC
ARDELYX INC.
ASTELLAS PHARMA INC.
ASTRAZENECA
CELGENE CORP.
CLOVIS ONCOLOGY
DAEWOONG PHARMACEUTICAL CO., LTD.
ELI LILLY AND COMPANY
GLAXOSMITHKLINE
HORIZON PHARMA PLC
IMMUNOGENX
IMMUNOMEDICS
MERCK & CO.
MERRIMACK PHARMACEUTICALS INC.
NEW LINK GENETICS
OTSUKA HOLDINGS CO. LTD.
PFIZER INC.
ROCHE
SANOFI
SHIRE
SUCAMPO PHARMACEUTICALS INC.
SYNERGY PHARMACEUTICALS INC.
SYNTHETIC BIOLOGICS
TAIHO PHARMACEUTICAL CO., LTD.
TAKEDA PHARMACEUTICALS
VALEANT PHARMACEUTICALS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report